InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by Fenimore Christopher R., Chief Financial Officer. Insider active across 1 companies, notably Regeneron Pharmaceuticals, INC.. Aggregated, 10 filings have been logged. The latest transaction was filed on 8 April 2022 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Declarations10 total
€1m2,450 shares@ €511.43870.0017% mcap7.5% of flow
Common Stock
SEC:0001708138-22-000039:0·
€1m2,000 shares@ €501.85340.0014% mcap6.0% of flow
Common Stock
SEC:0001883850-22-000029:0·
€158,830270 shares@ €588.25980.0002% mcap2.2% of flow
Common Stock
SEC:0001708138-21-000106·
€158,830270 shares@ €588.25980.0002% mcap1.0% of flow
Common Stock
SEC:0001708138-21-000106:0·
01,859 shares0
Common Stock
SEC:0001883850-21-000022·
01,859 shares0
Common Stock
SEC:0001883850-21-000022:0·
€5m8,719 shares@ €569.38690.0068% mcap69.0% of flow
Common Stock
SEC:0001104659-21-109328·
€5m8,719 shares@ €569.38690.0068% mcap29.8% of flow
Common Stock
SEC:0001104659-21-109328:0·
€2m13,500 shares@ €153.40940.0028% mcap28.8% of flow
Common Stock
SEC:0001237899-21-000017·
€2m13,500 shares@ €153.40940.0028% mcap12.4% of flow
Common Stock
SEC:0001237899-21-000017:0·
10 of 10 declarations
About Fenimore Christopher R.
Christopher R. Fenimore is the Chief Financial Officer at Regeneron Pharmaceuticals, Inc. As SVP Controller, he oversees the accounting and financial operations of the company. His expertise is essential for ensuring compliance and financial transparency within Regeneron Pharmaceuticals, Inc.
